NP / PA
Rexroad, Kristina
Rexroad, Kristina was paid $11K by Medicaid between Dec 2019 and Feb 2024, across 6 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 38% of everything it billed.
33Billing provider infoREXROAD, KRISTINA
TAYLORVILLE, IL 62568
TAYLORVILLE, IL 62568
33aNPI1912263963assigned 04/04/2012
33bProvider typeFamily Nurse Practitioner
28Total paid$11K
24GClaims296
24DCodes billed6
24AFirst – last monthDec 2019 – Feb 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Illinois
Rank by total paid#2,156 of 3,353
Median peer was paid$25K
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 16 | $206.24 | |
| 2020 | 69 | $480.60 | |
| 2021 | 30 | $1K | |
| 2022 | 45 | $2K | |
| 2023 | 94 | $5K | |
| 2024incomplete | 42 | $2K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 38% | 86 | 83 | $4K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 21% | 53 | 53 | $2K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 19% | 30 | 30 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 9.9% | 15 | 15 | $1K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.6% | 97 | 87 | $982.16 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.1% | 15 | 15 | $351.90 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.